SCHEDULE: Vanguard Reports 0% Stake in Surgery Partners After Realignment

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Surgery Partners Inc. following an internal corporate realignment.

Summary

• The Vanguard Group filed an Amendment No. 2 to its Schedule 13G for Surgery Partners Inc. (CUSIP: 86881A100).
• The filing reports that The Vanguard Group now beneficially owns 0.00 shares, representing 0% of the Common Stock of Surgery Partners Inc.
• This change is attributed to an internal realignment within The Vanguard Group, which became effective on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of Vanguard will report their beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities held by these subsidiaries and/or business divisions, in accordance with SEC Release No. 34-39538 (January 12, 1998).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as slightly negative due to the headline 0% ownership reported by The Vanguard Group, despite the explanation of an internal realignment. While the underlying shares may still be held by Vanguard's subsidiaries, the direct reporting entity no longer shows a stake, which could be misinterpreted by the market.

Positives

• The filing clarifies the reporting structure for Vanguard's holdings, indicating a more granular disclosure approach by its subsidiaries, which enhances transparency.
• The realignment ensures compliance with SEC reporting guidelines for large institutional investors, specifically regarding beneficial ownership disclosure.

Negatives

• The Vanguard Group, as the primary reporting entity, no longer reports any direct beneficial ownership in Surgery Partners Inc., which could be misinterpreted as a significant reduction in overall institutional interest from Vanguard-affiliated funds.
• The headline figure of 0% ownership from a major institutional investor like Vanguard might cause initial concern or negative sentiment among some investors if the underlying reason for the change is not fully understood.

Risks

• Potential misinterpretation by investors regarding Vanguard's overall investment in Surgery Partners, as the 0% reported by the parent entity does not necessarily mean a complete divestment by all Vanguard-affiliated funds.
• The change in reporting structure could lead to a perceived decrease in institutional ownership if the nuances of disaggregated reporting are not fully grasped, potentially impacting investor sentiment and the stock price.

Future Outlook

NA

Management Comments

• On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release.
• Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11.

Industry Context

StockSavvy.ai notes that large institutional investors like The Vanguard Group frequently adjust their internal reporting structures to optimize compliance and operational efficiency. This disaggregation of beneficial ownership reporting, while specific to Vanguard's internal realignment, reflects a broader trend among complex financial institutions to refine how holdings are disclosed, especially as regulatory scrutiny on beneficial ownership continues to evolve. It is not uncommon for such changes to occur without implying a fundamental shift in investment strategy towards the underlying issuer, Surgery Partners Inc.

Stakeholder Impact

• Shareholders: May experience short-term negative sentiment if the 0% ownership is misinterpreted as a full divestment by Vanguard, potentially leading to stock price volatility.
• Investment Professionals: Will need to understand the nuance of Vanguard's internal realignment and disaggregated reporting to accurately assess the true aggregate institutional ownership in Surgery Partners Inc. by Vanguard-affiliated entities.

Next Steps

• Vanguard's subsidiaries or business divisions will report their beneficial ownership separately for Surgery Partners Inc. in future filings.

Key Dates

Recommendation

While The Vanguard Group's direct reported ownership in Surgery Partners Inc. has dropped to 0% due to an internal realignment, this does not necessarily indicate a complete divestment by all Vanguard-affiliated funds. Investors should 'hold' and await further clarity on the aggregate holdings of Vanguard's disaggregated entities before making significant investment decisions. The change is primarily a reporting adjustment rather than a fundamental shift in investment thesis, but the initial market reaction could be negative.

Keywords

Surgery Partners Inc, Vanguard Group, Schedule 13G, beneficial ownership, institutional ownership, SEC filing, corporate realignment, common stock, investment adviser, healthcare services